Business
India
India
Aurobindo Pharma enters US inhalation market with generic Advair launch
The launch marks Aurobindo Pharma's entry into the US inhalation market and expands its complex generics portfolio beyond conventional oral solid formulations
Continue Reading on Business Standard
This article is aggregated from Business Standard. Click below to read the full story.
Bloomberg
The Guardian - Business